Related Experiment Videos
Microarray analysis of B-cell lymphoma cell lines with the t(14;18)
Ryan S Robetorye1, Sandra D Bohling, John W Morgan
1Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA.
The Journal of Molecular Diagnostics : JMD
|August 10, 2002
Summary
The t(14;18) genetic alteration in lymphoma leads to BCL-2 over-expression. Microarray analysis identified 137 differentially expressed genes, revealing new targets for follicular lymphoma and diffuse large B-cell lymphoma (DLBCL) research.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- The t(14;18) translocation is common in follicular lymphoma and some diffuse large B-cell lymphomas (DLBCL), causing BCL-2 over-expression.
- BCL-2 over-expression is crucial for lymphomagenesis but insufficient alone for malignant lymphoma development.
Purpose of the Study:
- To identify additional genes involved in follicular lymphoma genesis and DLBCL progression.
- To analyze global transcriptional changes in t(14;18)-positive lymphoma cell lines.
Main Methods:
- Gene expression profiling of t(14;18)-positive lymphoma cell lines and t(11;14)-positive mantle-cell lymphoma cell lines using cDNA microarrays.
- Comparison of gene expression profiles with purified B-cells from hyperplastic tonsils.
- Validation of differentially expressed genes using quantitative real-time PCR and immunoblotting.
Main Results:
- 137 genes showed at least twofold differential expression in t(14;18) cell lines compared to tonsillar B-cells.
- 68 genes were up-regulated (proliferation, survival, metabolism) and 69 down-regulated (cell adhesion, growth regulation).
- Hierarchical clustering distinguished t(14;18) and mantle-cell lymphoma cell lines; ~80% of selected gene changes were confirmed.
Conclusions:
- cDNA microarray analysis effectively assesses global transcriptional changes in t(14;18)-positive lymphoma cell lines.
- This approach identified novel genes potentially contributing to non-Hodgkin's lymphoma development and progression.
- Further research into these genes may offer new therapeutic targets for lymphomas with the t(14;18) translocation.